Check out and subscribe to the latest newsletter from Stevenage Bioscience Catalyst.
Highlights include:
- UBS Asset Management and Reef Group secure approval for one of Europe's largest Life Sciences campuses in Europe
- Cell and Gene Therapy, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapies
- Plasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogenic cell immunotherapies
- BioWednesday Stevenage: 6 September
Media Contact Information: